Cannabis Science Moves Ahead With FDA Clinical Trial Process
Robert Melamede, president and CEO of Cannabis Science, said: “We are in the final stages before Cannabis Science files with the FDA for clinical trials. There is a

Robert Melamede, president and CEO of Cannabis Science, said: “We are in the final stages before Cannabis Science files with the FDA for clinical trials. There is a

The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex’s development plan regarding the proposed preclinical

miR-122 is a liver-expressed microRNA that has been shown to be a critical endogenous ‘host factor’ for the replication of HCV and anti-miRs targeting miR-122 have been shown

In addition to a license agreement and Restraint Agreement, Derma Sciences and Comvita also entered into several other related agreements, including a collaborative research and development agreement, a

The US patent is expected to expire on October 30, 2022 and, in addition, the US PTO has granted a patent term adjustment of 300 days, leading to

KX2-391 is an inhibitor of Src kinase signaling and microtubule polymerisation and has a broad range of activity in cancer cell lines, including those that are resistant to

NextBio Enterprise offers life sciences organisations tools for knowledge discovery and collaboration, seamless integration of internal and external research data, and secure data access. Saeid Akhtari, co-founder and

Genta has recently completed a dose-ranging and pharmacokinetic study using Tesetaxel administered once every 3 weeks, a schedule that has shown anticancer activity in several Phase 2 clinical

LSO’s global Phase 3 trial of Aptocine in metastatic colorectal cancer (MCRC) has reached target enrollment of 450 patients at 52 sites. The controlled, randomised MCRC trial is

HPLC is a seperation technique that utilizes different types of stationary phase, a pump generating a gradient of two different solvents, a steel enforced column and an apparatus